We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
TheraVet SA | EU:ALVET | Euronext | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.006 | 0.87% | 0.698 | 0.632 | 0.70 | 0.732 | 0.64 | 0.70 | 18,725 | 16:40:00 |
Regulatory News:
TheraVet (ISIN: BE0974387194 - ticker: ALVET) (Paris:ALVET), a pioneering company in the management of osteoarticular diseases in pets, announced today its participation in the annual congress of the European Society of Veterinary Orthopaedics and Traumatology (ESVOT) which will be held from 21 to 24 September at the Acropolis in Nice, France.
With nearly 1000 participants, this event is the largest specialised congress in veterinary orthopaedics and traumatology in Europe, bringing together high-quality international speakers and therefore represents a prime showcase for the Company. ESVOT is chaired by Pr. Marc Balligand, who is also the President of the Scientific Advisory Board of TheraVet.
The Company will be particularly well represented with 3 scientific communications. The results obtained through close collaborations with renowned veterinarians will be presented during this conference, proof of the growing interest of the veterinary community in the Company's products:
The Company will also have a strong commercial presence for its BIOCERA-VET® products, including:
- Drylab sessions allowing veterinarians to test and evaluate the performance of the products, - Videos demonstrating the use of the products in real clinical cases, - Coupons, promotional documents…
About TheraVet SA TheraVet is a veterinary biotechnology company specialising in osteoarticular treatments for companion animals. The Company develops targeted, safe and effective treatments to improve the quality of life of pets suffering from joint and bone diseases. For pet owners, the health of their pets is a major concern and TheraVet’s mission is to address the need for innovative and curative treatments. TheraVet works closely with international opinion leaders in order to provide a more effective response to ever-growing needs in the field of veterinary medicine. TheraVet is listed on Euronext Growth® Paris and Brussels, has its head office in Belgium (Gosselies) with a US subsidiary in Texas. For more information, visit the TheraVet website or follow us on LinkedIn / Facebook / Twitter
About BIOCERA-VET In close collaboration with an international scientific board, THERAVET® has developed a new line of calcium-phosphate and biological bone substitutes, BIOCERA-VET®. BIOCERA-VET® is a full range of innovative, easy-to-use, efficient & cost-effective bone substitutes indicated in bone surgeries where a bone graft is required and as a palliative alternative in the management of canine osteosarcoma. Based on extremely promising clinical results, this line offers the possibility of a better, more convenient and more efficient orthopedic surgery.
BIOCERA-VET® is declined in different lines:
For more information, visit BIOCERA-VET website.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220918005014/en/
TheraVet Chief Operating Officer Sabrina Ena investors@thera.vet Tel: +32 (0) 71 96 00 43
Chief Corporate Officer Julie Winand investors@thera.vet
NewCap Investor Relations and Financial Communications Théo Martin / Hugo Willefert theravet@newcap.eu Tel: +33 (0)1 44 71 94 94
Press Relations Arthur Rouillé theravet@newcap.eu Tel: +33 (0)1 44 71 00 15
NewCap Belgique Press Relations Laure-Eve Monfort lemonfort@thera.vet Tel: + 32 (0) 489 57 76 52
1 Year TheraVet Chart |
1 Month TheraVet Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions